Abstract The c-Myb transcription factor is a critical regulator of proliferation and stem cell differentiation, and mutated alleles of c-Myb are oncogenic, but little is known about changes in c-Myb activity during the cell cycle. Previous studies have shown that the specificity of c-Myb depends in part on its DNA binding domain, but also on protein-protein interaction motifs in the C-terminal regulatory domains of the protein. These interactions are likely subject to regulation by post-translational modifications and are modified in oncogenic derivatives of c-Myb, which regulate different sets of target genes than the normal c-Myb protein. The analysis of cell cycle regulated target genes provides an ideal means of following the regulation of c-Myb activity in different subsets of cells that are in distinct cell cycle phases. Using Chromatin Immunoprecipitation (ChIP) assays, we found that c-Myb associated with some target genes only in specific cell cycle stages. For example, with the Cyclin E1 gene promoter only in G2/M phase cells. However, we also found that the levels of c-Myb protein were dramatically affected by treating with some cell cycle blocking agents. To map the association of c-Myb with specific target genes during the cell cycle, we developed a novel Fix-Sort-ChIP approach, in which asynchronously growing cells were fixed with formaldehyde, stained with Hoechst 33342 and separated into different cell cycle fractions by flow sorting, then processed for ChIP assays. This approach showed that the specificity of c-Myb is dramatically different in small subpopulations of cells, for example cells in the G2/M phase of the cell cycle, than in the bulk population. The repositioning of c-Myb during the cell cycle is not due to changes in its expression and also occurs with ectopically expressed, epitope-tagged versions of c-Myb. The repositioning occurs in established cell lines, in primary human CD34+ hematopoietic progenitors and in primary human acute myeloid leukemia cells. Our results suggest that c-Myb specificity is actively regulated during the cell cycle, probably through changes in protein-protein interactions. This sheds new light on the dynamic nature of gene regulation during the cell cycle and on the importance of post-translational modifications and/or oncogenic mutations that can dramatically alter the activity and the specificity of transcription factors like c-Myb. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 2157. doi:10.1158/1538-7445.AM2011-2157